🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives of the study: This randomized multicenter phase II study compar...
Status
Terminated
Location
Free University Hospital
Start Date
2004-10
Trial ID
NCT00851110
Treatments Being Tested
This prospective trial will assess the activity and feasibility of a new hi...
Status
Completed
Location
San Raffaele Scientific Institute
Start Date
2007-01
Trial ID
NCT00801216
Treatments Being Tested
Objective: To compare the effect and safety of autologous transplantation ...
Status
Completed
Location
the southwest Hospital
Start Date
2009-08
Trial ID
NCT00955669
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Centre Paul Papin
Start Date
1994-12
Trial ID
NCT00002870
The purpose of this research study is to determine the safety of CT-011 alo...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2010-03
Trial ID
NCT01067287
Treatments Being Tested
The purpose of this Phase 2 randomized study is to evaluate the efficacy an...
Status
Completed
Location
Wilhelminenspital-1
Start Date
2007-10
Trial ID
NCT00531453
Rituximab vs observation after high-dose consolidative first-line chemother...
Status
Terminated
Location
Hôpital Henri Mondor
Start Date
1999-10
Trial ID
NCT00169169
Treatments Being Tested
The purpose of this trial is to confirm the safety and efficacy of high-dos...
Status
Completed
Location
Rush University Medical Center
Start Date
2012-12
Trial ID
NCT01660633
Treatments Being Tested
The primary purpose of the study will be testing the dosing of temozolomide...
Status
Terminated
Location
Cedars Sinai Medical Center
Start Date
2010-10-14
Trial ID
NCT01235793
Treatments Being Tested
This is an open-label, Phase II, single center trial of pembrolizumab (MK-3...
Status
Terminated
Location
John Theurer Cancer Center-Hackensack Meridian Health
Start Date
2016-12-12
Trial ID
NCT02906332
Treatments Being Tested